Sir Run Run Shaw Hospital, or Shao Yifu Hospital, is a hospital affiliated with the Medical School of Zhejiang University, in Hangzhou, Zhejiang, China.

There are 1,200 beds in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital.

During the past decade, Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Beijing Chao Yang Hospital" with 2 trials sponsored, "Sir Run Run Shaw Hospital" with 2 trials sponsored, "Changlin Mei" with 1 trials sponsored and "Daehwa Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 1 trials as a collaborator, "Fuzhou General Hospital" with 1 trials as a collaborator, "Hebei Medical University Third Hospital" with 1 trials as a collaborator and "Hebei Province Center for Reproductive Medicine" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are "Stroke" (4 trials), "Pulmonary Embolism" (2 trials), "Thromboembolism" (2 trials), "Advanced Breast Cancer" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" in a lesser frequency.

Most popular intervention types in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are "Drug" (14 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASA 100 mg" (1 trials), "BI 456906" (1 trials), "Binimetinib" (1 trials) and "BoNT-A injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".